Your browser doesn't support javascript.
loading
Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy.
Strasser-Weippl, Kathrin; Horick, Nora; Smith, Ian E; O'Shaughnessy, Joyce; Ejlertsen, Bent; Boyle, Frances; Buzdar, Aman U; Fumoleau, Pierre; Gradishar, William; Martin, Miguel; Moy, Beverly; Piccart-Gebhart, Martine; Pritchard, Kathleen I; Lindquist, Deborah; Rappold, Erica; Finkelstein, Dianne M; Goss, Paul E.
Afiliação
  • Strasser-Weippl K; Center for Oncology and Hematology, Wilhelminen Hospital, Vienna, Austria. Electronic address: kathrin.strasserweippl@gmail.com.
  • Horick N; Massachusetts General Hospital Biostatistics Center, Boston, MA, USA. Electronic address: nhorick@partners.org.
  • Smith IE; Royal Marsden Hospital, London, UK. Electronic address: ian.smith@rmh.nhs.uk.
  • O'Shaughnessy J; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. Electronic address: Joyce.OShaughnessy@usoncology.com.
  • Ejlertsen B; Rigshospitalet, DBCG Secretariat, Copenhagen, Denmark. Electronic address: ejlertsen@dadlnet.dk.
  • Boyle F; Mater Hospital, North Sydney, NSW, Australia. Electronic address: franb@bigpond.net.au.
  • Buzdar AU; University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: abuzdar@mdanderson.org.
  • Fumoleau P; Centre GF Leclerc, Dijon, France. Electronic address: pfumoleau@cgfl.fr.
  • Gradishar W; Northwestern University, Chicago, IL, USA. Electronic address: WGradishar@nmff.org.
  • Martin M; Hospital Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain. Electronic address: mmartin@geicam.org.
  • Moy B; Massachusetts General Hospital, Boston, MA, USA. Electronic address: bmoy@partners.org.
  • Piccart-Gebhart M; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: martine.piccart@bordet.be.
  • Pritchard KI; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada. Electronic address: kathy.pritchard@sunnybrook.ca.
  • Lindquist D; Arizona Oncology, US Oncology, Sedona, AZ, USA. Electronic address: deborah.lindquist@usoncology.com.
  • Rappold E; GlaxoSmithKline, Collegeville, PA, USA. Electronic address: mprcer@gmail.com.
  • Finkelstein DM; Massachusetts General Hospital Biostatistics Center, Boston, MA, USA. Electronic address: dfinkelstein@partners.org.
  • Goss PE; Massachusetts General Hospital, Boston, MA, USA. Electronic address: pgoss@partners.org.
Eur J Cancer ; 56: 85-92, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26829011
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinazolinas / Neoplasias da Mama / Inibidores de Proteínas Quinases / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2016 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinazolinas / Neoplasias da Mama / Inibidores de Proteínas Quinases / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2016 Tipo de documento: Article País de publicação: Reino Unido